HomeAI · summaries
Storia in 2 fonti
FDA Advisory Panel to Assess Peptide Bulk Drug Substances from Obesity to Opioid
FDA will review BPC-157, TB-500, Semax, and other peptides in July as it considers additions to the 503A Bulks List.
Confronto fonti
2 prospettive sulla stessa storiaTimeline cronologica
- ·
washingtonexaminer.com
Peptide exceptionalism is a dangerous FDA loophole
If a compound is powerful enough to treat disease, alter metabolism, or change human physiology, it is powerful enough to harm.
- ·
benzinga.com
FDA Advisory Panel to Assess Peptide Bulk Drug Substances from Obesity to Opioid
FDA will review BPC-157, TB-500, Semax, and other peptides in July as it considers additions to the 503A Bulks List.